42.17 USD
▲+0.63+1.52%
盘后 42.80 +1.49%
2026-09-15
市值
$2.46B
市盈率
13.66
EPS
3.09
股息率
—
52 周区间
25.52 – 43.49
成交量
1.21M
Beta
0.93
目标价
47.36
52W 低 25.5252W 高 43.49
价格走势
公司简介
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also develops Pitolisant that is in Phase 3 clinical trial for the treatment of Prader-Willi Syndrome (PWS); in Phase 2 clinical trial to treat Myotonic Dystrophy (DM1); and is in P...